CD8A and neoplasm: In the vaccinated group, immune monitoring revealed significant increases (i) of delayed-type hypersensitivity (DTH) reactivity of the skin towards autologous tumor cells, (ii) of numbers of tumor-reactive MTCs in peripheral blood and (iii) of numbers of CD8+ TILs in secondary tumors.